| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8215218 | International Journal of Radiation Oncology*Biology*Physics | 2016 | 28 Pages |
Abstract
Diabetic patients not using metformin independently have significantly higher rates of distant metastases than do nondiabetic patients, whereas metformin users have rates of distant metastases similar to those of nondiabetic patients. Further prospective investigation is warranted to validate the benefit of metformin in oropharyngeal cancer.
Related Topics
Physical Sciences and Engineering
Physics and Astronomy
Radiation
Authors
Daniel E. MD, Beth M. MD, PhD, Zachary S. MD, Andrew BS, Heath D. MD, PhD, Joseph R. MD, PhD, Adam S. MD, Nancy Y. MD,